133 related articles for article (PubMed ID: 19348192)
21. An open study on the efficacy and safety of transurethral needle ablation of the prostate in treating symptomatic benign prostatic hyperplasia: the University of Florida experience.
Kahn SA; Alphonse P; Tewari A; Narayan P
J Urol; 1998 Nov; 160(5):1695-700. PubMed ID: 9783934
[TBL] [Abstract][Full Text] [Related]
22. [The effect of intra-urethral catheter for prostatic hypertrophy patients who are unfit for operation and suffer from urinary retention].
Takeda M; Sasagawa T; Saito K; Tsutsui T; Takahashi H; Go H; Nishiyama T; Hatano A; Watanabe R; Saito T
Nihon Hinyokika Gakkai Zasshi; 1992 May; 83(5):605-10. PubMed ID: 1379655
[TBL] [Abstract][Full Text] [Related]
23. [Urethral stent (Memotherm) for the treatment of benign prostatic hyperplasia].
Noda Y; Ujike T; Oka D; Takada S; Fujimoto N; Koide T
Hinyokika Kiyo; 2003 Nov; 49(11):645-7. PubMed ID: 14719451
[TBL] [Abstract][Full Text] [Related]
24. [Application of urethral stent under metal bougie guidance].
Isogawa Y; Ohmori K
Hinyokika Kiyo; 1993 Mar; 39(3):231-5. PubMed ID: 7685141
[TBL] [Abstract][Full Text] [Related]
25. A simple, self-retaining intraurethral catheter for treatment of prostatic obstruction.
Nissenkorn I; Richter S; Slutzker D
Eur Urol; 1990; 18(4):286-9. PubMed ID: 1705227
[TBL] [Abstract][Full Text] [Related]
26. [Prevention of temporary prostatic obstruction after high-energy microwave thermothery by placement of prostatic bridge catheter].
Djavan B; Seitz C; Fakhari M; Ghawidel K; Marberger M
Prog Urol; 1999 Apr; 9(2):261-70. PubMed ID: 10370950
[TBL] [Abstract][Full Text] [Related]
27. High-energy transurethral microwave thermotherapy for large severely obstructing prostates and the use of biodegradable stents to avoid catheterization after treatment.
Dahlstrand C; Grundtman S; Pettersson S
Br J Urol; 1997 Jun; 79(6):907-9. PubMed ID: 9202557
[TBL] [Abstract][Full Text] [Related]
28. Comparison of nitinol urethral stent infections with indwelling catheter-associated urinary-tract infections.
Egilmez T; Aridogan IA; Yachia D; Hassin D
J Endourol; 2006 Apr; 20(4):272-7. PubMed ID: 16646656
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the effects of temporary covered nitinol stent placement in the prostatic urethra: short-term study in the canine model.
Crisóstomo V; Song HY; Maynar M; Sun F; Soria F; Lima JR; Yoon CJ; Usón-Gargallo J
Cardiovasc Intervent Radiol; 2007; 30(4):731-7. PubMed ID: 17436035
[TBL] [Abstract][Full Text] [Related]
30. Temporary placement of covered retrievable expandable nitinol stents with barbs in high-risk surgical patients with benign prostatic hyperplasia: work in progress.
Kim CS; Song HY; Jeong IG; Yeo HJ; Kim EY; Park JH; Yoon CJ; Paick SH; Park SW; Bae JI; Won JH
J Vasc Interv Radiol; 2011 Oct; 22(10):1420-6. PubMed ID: 21840225
[TBL] [Abstract][Full Text] [Related]
31. Prostatic and periprostatic interstitial temperature measurements in patients treated with transrectal thermal therapy (local intracavitary microwave hyperthermia).
Kaplan SA; Shabsigh R; Soldo KA; Olsson CA
J Urol; 1992 Jun; 147(6):1562-5. PubMed ID: 1375661
[TBL] [Abstract][Full Text] [Related]
32. Long-term result of Memokath urethral sphincter stent in spinal cord injury patients.
Vaidyanathan S; Soni BM; Oo T; Sett P; Hughes PL; Singh G
BMC Urol; 2002 Nov; 2():12. PubMed ID: 12427256
[TBL] [Abstract][Full Text] [Related]
33. A good alternative to indwelling catheter owing to benign prostate hyperplasia in elderly: Memotherm prostatic stent.
Bozkurt IH; Yalcinkaya F; Sertcelik MN; Zengin K; Ekici M; Yigitbasi O
Urology; 2013 Nov; 82(5):1004-7. PubMed ID: 23992964
[TBL] [Abstract][Full Text] [Related]
34. A new self-retaining intraurethral device. An alternative to an indwelling catheter in patients with urinary retention due to infravesical obstruction.
Nissenkorn I; Richter S
Br J Urol; 1990 Feb; 65(2):197-200. PubMed ID: 1690585
[TBL] [Abstract][Full Text] [Related]
35. Temporary placement of a covered, retrievable, barbed stent for the treatment of hormone-induced benign prostatic hyperplasia: technical feasibility and histologic changes in canine prostates.
Yoon CJ; Song HY; Kim JH; Park HG; Kang HS; Ro JY; Hong JH
J Vasc Interv Radiol; 2010 Sep; 21(9):1429-35. PubMed ID: 20688535
[TBL] [Abstract][Full Text] [Related]
36. [Experience with polyurethane intraurethral stents in aged patients].
Tsujimoto Y; Yoshimoto T
Hinyokika Kiyo; 1993 Jun; 39(6):533-9. PubMed ID: 7687814
[TBL] [Abstract][Full Text] [Related]
37. Biodegradable braided poly(lactic-co-glycolic acid) urethral stent combined with dutasteride in the treatment of acute urinary retention due to benign prostatic enlargement: a pilot study.
Kotsar A; Isotalo T; Juuti H; Mikkonen J; Leppiniemi J; Hänninen V; Kellomäki M; Talja M; Tammela TL
BJU Int; 2009 Mar; 103(5):626-9. PubMed ID: 18990149
[TBL] [Abstract][Full Text] [Related]
38. The urolume, a permanently implanted prostatic stent for patients at high risk for surgery. Results from 5 collaborative centres.
Williams G; Coulange C; Milroy EJ; Sarramon JP; Rubben H
Br J Urol; 1993 Sep; 72(3):335-40. PubMed ID: 7693296
[TBL] [Abstract][Full Text] [Related]
39. Prostatic stents. Current perspectives for the management of benign prostatic hyperplasia.
Kletscher BA; Oesterling JE
Urol Clin North Am; 1995 May; 22(2):423-30. PubMed ID: 7539187
[TBL] [Abstract][Full Text] [Related]
40. [Clinical study of intraurethral stent for patients with benign prostatic hypertrophy with 1-year follow up].
Ito T; Fujita K; Hori T; Sakagami H
Hinyokika Kiyo; 1994 Jul; 40(7):593-5. PubMed ID: 7521984
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
